A particular problem of urolithiasis (Urolithiasis) is the high frequency of recurrent stone formation. According to statistics, after 1 year, about 10% of patients have a relapse, after five years - 50% of patients. Removal of stones does not guarantee the absence of possible recurrent stone formation.
Patients at high risk of stone formation need to carry out specific prevention of relapse, which, as a rule, is medication and is based on an analysis of the composition of the stone. (Clinical guidelines EAU / 2017 (European Association of Urology))
Today, the analysis of the composition of stones is not mandatory by medical standards, and therefore little known to doctors and patients. The high cost of equipment, the complexity of the analysis, the lack of a knowledge base and research are the result of low qualifications of specialists in this area.
The project for the study of the mineralization of the human body (urolithiasis, ICD) - represents the most modern methods of analyzing the chemical composition of kidney stones, using IR spectrometry and X-ray phase analysis. The result of this analysis is a protocol indicating the name of the mineral and its percentage in the biomaterial (stone).
Based on the results of a qualitatively conducted analysis, the urologist determines the type of stone and is able to accurately prescribe further preventive and anti-relapse treatment of patients with ICD, thereby minimizing the risk of re-formation of stone in the human body.